Page last updated: 2024-08-23

etoposide and Abnormalities, Autosome

etoposide has been researched along with Abnormalities, Autosome in 139 studies

Research

Studies (139)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (4.32)	18.7374
1990's	49 (35.25)	18.2507
2000's	60 (43.17)	29.6817
2010's	21 (15.11)	24.3611
2020's	3 (2.16)	2.80

Authors

Authors	Studies
Bouffet, E; Chapman, RJ; Dineen, RA; Ellison, DW; Giagnacovo, M; Grundy, RG; Jacques, TS; Jaspan, T; Kilday, JP; Macarthur, D; Mallucci, C; Modena, P; Paine, SML; Pajtler, KW; Ritzmann, TA; Thorp, N	1
de Campos Nebel, M; González-Cid, M; Palmitelli, M; Pérez Maturo, J	1
Atkin, ND; Raimer, HM; Wang, YH; Wang, Z; Zang, C	1
Bhat, VS; Eastmond, DA; Gollapudi, P	1
Audisio, E; D'Ardia, S; Di Bello, C; Di Celle, PF; Frairia, C; Inghirami, G; Marmont, F; Messa, E; Pich, A; Riera, L; Sismondi, F; Toppino, D; Vitolo, U	1
Bersonda, J; Ji, Z; McHale, CM; Smith, MT; Tung, J; Zhang, L	1
de Campos-Nebel, M; González-Cid, M; Palmitelli, M	1
Cinelli, S; Mosesso, P; Ottavianelli, A; Pepe, G; Schinoppi, A	1
Alonzo, T; Auvrignon, A; Balwierz, W; Beverloo, HB; Bongers, M; Cloos, J; Creutzig, U; De Moerloose, B; Dworzak, M; Forestier, E; Fynn, A; Gibson, B; Harrison, CJ; Hirsch, B; Johnston, D; Kaspers, G; Klein, K; Lee, V; Pession, A; Popa, A; Raimondi, S; Reedijk, A; Reinhardt, D; Rubnitz, J; Salgado, C; Taga, T; Tawa, A; Zapotocky, M; Zeller, B; Zimmerman, M	1
Bhatnagar, B; Blum, W; Canning, R; Devine, SM; Garzon, R; Geyer, S; Klisovic, R; Marcucci, G; Vasu, S; Walker, AR; Walsh, K; Wang, H; Wu, YZ	1
Advani, RH; Armand, P; Chapuy, B; Connelly, CF; Daadi, SE; de Jong, D; Freeman, GJ; Homer, H; Hoppe, RT; Ligon, AH; Natkunam, Y; Neuberg, DS; Redd, RA; Rodig, SJ; Roemer, MG; Shipp, MA; Sun, HH	1
Chaika, ZV; Durnev, AD; Kulakova, AV; Pligina, KL; Zhanataev, AK	1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR	1
Libura, J; Richardson, C; Solecka, J; Ward, M	1
Marschalek, R	1
Advani, A; Kalaycio, M; Pohlman, B; Rybicki, L; Sekeres, M; Sobecks, R; Tripp, B	1
Barjesteh van Waalwijk van Doorn-Khosrovani, S; Ruijters, E; van Schooten, FJ; Vanhees, K	1
Jones, RL; Kulkarni, S; Mehta, J; Morgan, G; Potter, M; Powles, R; Saso, R; Singhal, S; Sirohi, B; Smith, K; Swansbury, GJ; Treleaven, J	1
Al-Anteet, AA; Al-Harbi, MM; Al-Rasheed, NM; Alhaider, AA; Attia, SM	1
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D	1
Aruga, C; Aubrecht, J; Bauer, D; Boitier, E; Deng, S; Dickinson, D; Ellinger-Ziegelbauer, H; Fornace, AJ; Fostel, JM; Grenet, O; Gu, Y; Hoflack, JC; Le Fevre, AC; Shiiyama, M; Smith, R; Snyder, RD; Spire, C; Tanaka, G	1
Hu, NP; Hu, XM; Li, L; Liu, C; Liu, F; Ma, R; Wang, HZ; Xiao, HY; Xu, YG; Yang, XH; Zhang, SS; Zheng, CM	1
Bueno, C; Catalina, P; García-Pérez, JL; Ligero, G; Melen, GJ; Menendez, P; Montes, R; Sánchez, L	1
Darroudi, F; de Groot, J; de Winter, JP; Godthelp, BC; Joenje, H; Oostra, AB; Scheper, RJ; Steltenpool, J; van der Lelij, P; van Gosliga, D; van Zon, W; Waisfisz, Q; Wolthuis, RM	1
Aplan, PD; Cheng, Y; Keenan, B; Nakahara, K; Roschke, AV; Zhang, Z	1
Mateos, MV; San-Miguel, JF	1
Betts, DR; Bourquin, JP; Bradtke, J; Creutzig, U; Dworzak, MN; Haas, OA; Reinhardt, D; Sander, A; Stary, J; von Neuhoff, C; Zemanova, Z; Zimmermann, M	1
Celentano, M; Criscuolo, C; Ferrara, F; Izzo, T; Mele, G; Riccardi, C	1
Bandopadhyay, G; Bowman, KJ; Braker, P; Coyle, B; Grundy, RG; Heath, R; Hussein, D; Jones, GD; Kerr, ID; Kumari, R; Lowe, J; Miller, S; Othman, R; Ottoman, R; Peet, A; Punjaruk, W; Rahman, R; Shaw, L; Storer, LC; Watson, S	1
Ganser, A; Göhring, G; Hofmann, W; Lehmann, U; Luna, JC; Manukjan, G; Otto, N; Scherer, R; Schlegelberger, B; Steinemann, D; Welte, K	1
Aten, JA; Borovski, T; Cijsouw, T; Franken, NA; Kanaar, R; Krawczyk, PM; Medema, JP; Stap, J; ten Cate, R	1
Chan, M; Chen, H; DeVito, GL; Murli, H; Roberts, DJ; Sanok, K; Spellman, RA; Stankowski, LF; Thakur, AK; Yurt, P	1
Karmakar, P; Mukherjee, A	1
Atkinson, HD; Colovic, M; Colovic, N; Jankovic, G; Kraguljac, N; Radojkovic, M; Stanisavljevic, D; Suvajdzic, N; Tomin, D; Vidovic, A	1
Creutzig, U; Reinhardt, D; Sander, A; Von Neuhoff, C	1
de Campos-Nebel, M; Elguero, ME; González-Cid, M	1
Bahng, HS; Jang, GD; Jeong, YH; Ji, HS; Kim, EK; Kim, SH; Kim, SW; Kim, WK; Lee, JS; Park, CJ; Park, IG; Suh, CW; Suh, EJ	1
Joel, SP; Liu, WM; Oakley, PR	1
Furuichi, Y; Goto, M; Hayashi, M; Honma, M; Sakamoto, H; Satoh, T; Sofuni, T; Sugimoto, M; Tadokoro, S; Tanabe, H	1
Adler, ID; Attia, SM; Badary, OA; Hamada, FM; Schmid, TE	1
Creutzig, U; Hählen, K; Harbott, J; Huismans, DR; Kaspers, GJ; Pieters, R; Slater, RM; Veerman, AJ; Zimmermann, M; Zwaan, CM	1
Staudt, LM; Wilson, WH	1
Cardoso, RS; Dias, FL; Guimarães, AP; Kronka, SN; Sakamoto-Hojo, ET	1
Kadowaki, S; Kawakami, K; Watanabe, Y	1
Marchetti, F; Wyrobek, AJ	1
Bogush, TA; Kolomiets, OL; Sukhacheva, TV	1
Okamoto, Y; Pui, CH; Razzouk, BI; Ribeiro, RC; Shenep, JL; Srivastava, DK	1
Fil'chenkov, AA; Nesina, IP; Smirnova, IA; Zavelevich, MP	1
Cassina, G; Di-Tomaso, MV; Folle, GA; Martínez-López, W; Méndez-Acuña, L; Obe, G; Palitti, F	1
Fowler, P; Parry, EM; Parry, JM; Quick, E	1
Hunsicker, PR; Kerley, M; Pyle, A; Russell, LB; Saxton, AM	1
Afshar, F; Besser, GM; Geddes, J; Plowman, PN; Shipley, J; Summersgill, B	1
Balis, F; Bates, S; Cole, D; Egorin, MJ; Flynn, BM; Fojo, T; Knutsen, T; Langham, G; Rao, VK; Ried, T; Steinberg, SM; Wangsa, D	1
Muehlbauer, PA; Schuler, MJ	1
Bloomfield, CD; Carroll, AJ; Edwards, CG; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Sterling, LJ; Vardiman, JW	1
Bishop, JB; Marchetti, F; Pearson, FS; Wyrobek, AJ	1
Bestor, TH; Damelin, M; Sodja, VB; Sun, YE	1
Imoto, I; Inazawa, J; Katsuki, Y; Mizutani, S; Nagasawa, M; Nakada, S; Yokoyama, T	1
Blennow, E; Ernberg, I; Fadeel, B; Henter, JI; Karpova, MB; Nordenskjöld, M; Schoumans, J; Smirnov, AF	1
Kaufmann, WK	1
Eastmond, DA; Roy, SK; Wang, L	1
Kantidze, OL; Razin, SV	1
Bieth, E; Brennetot, C; Hofman, P; Pedeutour, F; Rouzier, C; Soler, C	1
Basecke, J; Becker, A; Glass, B; Griesinger, F; Haase, D; Podleschny, M; Schmitz, N; Schwiers, I; Schwiers, R; Seiffert, E; Trumper, L	1
Aluigi, MG; Cimoli, G; De Sessa, F; Mazzoni, A; Noviello, E; Parodi, S; Rovini, E; Russo, P	1
Creutzig, U; Harbott, J; Löffler, H; Ludwig, WD; Riehm, H; Ritter, J; Schellong, G; Sperling, C; Zimmermann, M	1
Agarwal, K; Mukherjee, A; Sen, S	2
Cavolina, P; Di Leonardo, A; Maddalena, A	1
Caporossi, D; De Salvia, R; Degrassi, F; Nicoletti, B; Palitti, F; Porfirio, B; Tanzarella, C	1
Ikeda, T; Nakaike, S; Nakane, S; Ohsawa, M; Suzuki, H; Yamagishi, T	1
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ	1
Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E	1
Castel, V; Esquembre, C; Ferris, J; López-Andreu, JA; Verdeguer, A	1
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS	1
Nakane, S; Suzuki, H	1
Andersson, M; Daugaard, G; Ersbøll, J; Hansen, SW; Hou-Jensen, K; Larsen, SO; Nielsen, D; Pedersen-Bjergaard, J; Philip, P; Sigsgaard, TC	1
Boogaerts, M; Bosly, A; Carli, MG; Castoldi, G; Cuneo, A; Demuynck, H; Doyen, C; Ferrant, A; Michaux, JL; Piva, N	1
Alberto, P; Beris, P; Cabrol, C; Jotterand Bellomo, M; Mermillod, B; Zulian, GB	1
Akatsuka, J; Furukawa, T; Nakazawa, S; Nishimura, K; Ohira, M; Okawa, Y; Sugita, K; Tsuchida, M	1
Andoh, T; Aratani, Y; Koyama, H	1
London, SN; Mailhes, JB; Marchetti, F; Young, D	1
Doi, T; Kobayashi, D; Koike, K; Kougo, Y; Matsunaga, T; Muramatsu, H; Niitsu, Y; Sakamaki, S; Sato, T; Watanabe, N	1
Belotti, D; Corneo, G; Maffè, PF; Pogliani, EM; Rivolta, GF	1
Kakihara, T; Kataoka, S; Kishi, K; Okada, R; Tanaka, A; Uchiyama, M; Watanabe, A; Yamamoto, K	1
Kallio, M; Lähdetie, J	1
Ohsawa, M; Suzuki, H; Tarumoto, Y	1
Barclay, L; Ernst, S; Ko, E; Martin, RH; Rademaker, A; Summers, N	3
Antoccia, A; Cimini, D; Degrassi, F; Tanzarella, C	1
Darroudi, F; Mosesso, P; Natarajan, AT; Palitti, F; van den Berg, M; Vermeulen, S	1
Crump, M; Dubé, I; Girouard, C; Imrie, KR; Keating, A; Prince, HM	1
Armstrong, MJ; Bradt, CI; Galloway, SM; Greenwood, SK; Hill, RB; Hilliard, CA; Johnson, TE	1
Armstrong, MJ; Bean, CL; Galloway, SM; Miller, JE; Nichols, WW; Skopek, TR	1
Ambra, R; Antonelli, A; Bucci, B; D'Agnano, I; Elli, R; Marcucci, L; Petrinelli, P; Zupi, G	1
Alessandrino, EP; Bernasconi, C; Bernasconi, P; Bonfichi, M; Brusamolino, E; Canevari, A; Castagnola, C; Castelli, G; Lazzarino, M; Pagnucco, G	1
Fuscoe, JC; Hanley, NM; Knapp, GW; Pui, CH; Relling, MV; Sandlund, JT; Setzer, RW	1
Sumner, AT	2
Martin, R	1
Kagan, VE; Tyurina, YY	1
Alekseenko, LL; Artsybasheva, IV; Grinchuk, TM; Meliksetian, MB; Pavlenko, MA; Pugovkina, NA	1
Burns, EM; Christopoulou, L; Corish, P; Tyler-Smith, C	1
Enomoto, T; Katada, T; Masuko, T; Narita, Y; Seki, M; Sonoda, E; Takeda, S; Wang, W; Yamada, K	1
Camitta, B; Carroll, AJ; Chang, M; Gresik, MV; Raimondi, SC; Ravindranath, Y; Steuber, CP; Weinstein, H	1
Brøgger, A; Fosså, SD; Hernandez, AM; Kat, A; Skovlund, E	1
Ambros, PF; Blohm, ME; Bolkenius, M; Calaminus, G; Gnekow, AK; Göbel, U; Harms, D; Heidemann, PH; Schneider, DT; von Schweinitz, D; Weinel, P	1
Bishop, JB; Generoso, WM; Hozier, J; Lowe, X; Marchetti, F; Wyrobek, AJ	1
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A	1
Kamiguchi, Y; Tateno, H	1
Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Mandelli, F; Martinelli, G; Mecucci, C; Petti, MC; Piccaluga, PP; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Tura, S; Visani, G	1
Ahmed, T; Feldman, EJ; Kancherla, R; Liu, D; Papageorgio, C; Pozzuoli, M; Seiter, K; Sreekantaiah, C; Weisberger, J; Weiss, M	1
Abramson, S; Byrnes, M; Cheung, IY; Cheung, NK; Dantis, E; Finn, R; Gerald, W; Gollamudi, S; Heller, G; Kramer, K; Kushner, BH; LaQuaglia, M; Larson, SM; Mora, J; O'Reilly, RJ; Rosenfield, N; Wuest, D; Yeh, S	1
Burnett, AK; Chatters, S; Goldstone, AH; Grimwade, D; Harrison, CJ; Harrison, G; Oliver, F; Walker, H; Wheatley, K	1
Baudis, M; Bentz, M; Döhner, H; Fritz, B; Kloess, M; Lichter, P; Schwänen, C; Walenta, K; Wessendorf, S	1
Bazarov, A; Cao, J; Fritz, E; Golub, EI; Haaf, T; Lurz, R; Mann, W; Raderschall, E; Ropers, HH; Sedivy, JM; Smith, A	1
Bassi, L; Carloni, M; Fonti, E; Meschini, R; Palitti, F; Palma de la Peña, N	1
Fujita, K; Furuichi, Y; Imamura, O; Itoh, C; Matsumoto, T; Takeda, S	1
Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K	1
Bendix, K; Hokland, P; Kjeldsen, E; Kristensen, JS; Meyer, K; Nørgaard, JM; Olesen, G; Olesen, LH; Pedersen, B	1
Boletis, J; Chiras, T; Kosmas, C; Kostakis, A; Tsavaris, NB; Vadiaka, M	1
Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F	1
Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H	1
Botkin, C; Knutsen, T; Sieber, SM; Whang-Peng, J	1
Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J	1
Belin, T; Champlin, R; Gajewski, J; Lee, M; Nimer, S; Schiller, G; Territo, M	1
Elliott, S; Marlton, P; Meagher, D; Rodwell, R; Taylor, D; Taylor, K; Timms, P; White, S; Wiley, J; Wright, S	1
Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S	1
Benet, J; Caballín, MR; Egozcue, J; Genescà, A; Germà, JR; Miró, R	1
Antonelli, A; Bosi, R; Elli, R; Kobal, D; Marcucci, L; Petrinelli, P	1
Daugaard, G; Hansen, SW; Larsen, SO; Pedersen-Bjergaard, J; Philip, P; Rørth, M	1
Fujita, K; Harada, H; Miyoshi, Y; Mori, H; Niikura, H; Okada, S; Shimizu, T; Takizawa, Y; Terada, H	1
Aurias, A; Dutrillaux, B; Maraschin, J	1
DeVore, R; Hainsworth, JD; Johnson, DH; Whitlock, J	1
Covey, JM; Kao-Shan, CS; Kerrigan, D; Pommier, Y; Whang-Peng, J	1
Hansen, HH; Hansen, M; Osterlind, K; Pedersen, AG; Pedersen-Bjergaard, J; Philip, P	1
Eguchi, K; Nakajima, T; Ochi, H; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Suemasu, K; Suga, J; Tominaga, K	1
Nakajima, T; Ochi, H; Saijo, N; Shinkai, T; Suemasu, K; Tominaga, K	1

Reviews

14 review(s) available for etoposide and Abnormalities, Autosome

Article	Year
How to treat a newly diagnosed young patient with multiple myeloma. Hematology. American Society of Hematology. Education Program, 2009 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Chromosome Aberrations; Combined Modality Therapy; Disease Management; Doxorubicin; Endpoint Determination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Middle Aged; Molecular Diagnostic Techniques; Multicenter Studies as Topic; Multiple Myeloma; Myeloablative Agonists; Pyrazines; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide; Transplantation Conditioning	2009
Focus on lymphomas. Cancer cell, 2002, Volume: 2, Issue:5 Topics: Alemtuzumab; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Gene Expression; Humans; Interleukin-2; Lymphoma; Prednisone; Risk Factors; Rituximab; Survival; Vaccines; Vincristine	2002
Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxyadenosines; Double-Blind Method; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Hypotension; Immunocompromised Host; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Retrospective Studies; Sepsis; Streptococcal Infections; Viridans Streptococci	2003
Ovarian dysgerminoma and Apert syndrome. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Acrocephalosyndactylia; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Aberrations; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Humans; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Nucleic Acid Hybridization; Ovarian Neoplasms; Ovariectomy; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Remission Induction	2008
Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers. Leukemia & lymphoma, 1993, Volume: 9, Issue:4-5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosome Aberrations; Cytarabine; DNA Nucleotidylexotransferase; Etoposide; Female; Gene Rearrangement; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Vindesine	1993
Recycling and redox cycling of phenolic antioxidants. Annals of the New York Academy of Sciences, 1998, Nov-20, Volume: 854 Topics: Animals; Antioxidants; Chromosome Aberrations; Coenzymes; DNA Damage; Etoposide; Humans; Models, Biological; Oxidation-Reduction; Oxidative Stress; Phenols; Ubiquinone; Vitamin E	1998
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chromosome Aberrations; Cisplatin; Diseases in Twins; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Scapula; Shoulder Joint; Time Factors	2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Translocation, Genetic; Treatment Outcome	2001
Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Leukemia, 2001, Volume: 15, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Etoposide; Female; Humans; Idarubicin; Incidence; Karyotyping; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin	2001
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas. Annals of hematology, 2001, Volume: 80 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine	2001
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine	2002
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. The hematology journal : the official journal of the European Haematology Association, 2001, Volume: 2, Issue:3 Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load	2001
[Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Histiocytic Sarcoma; Humans; Male; Prednisolone; Remission Induction; Vincristine	1991
Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q. Annals of internal medicine, 1989, May-01, Volume: 110, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 11; Cisplatin; Doxorubicin; Dysgerminoma; Etoposide; Humans; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Testicular Neoplasms	1989

Trials

17 trial(s) available for etoposide and Abnormalities, Autosome

Article	Year
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study. Neuro-oncology, 2022, 06-01, Volume: 24, Issue:6 Topics: Child; Chromosome Aberrations; Cyclophosphamide; Ependymoma; Etoposide; Follow-Up Studies; Histones; Humans; Treatment Outcome; Vincristine	2022
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia. American journal of hematology, 2008, Volume: 83, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction	2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leukemia & lymphoma, 2008, Volume: 49, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome	2008
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy. Chinese journal of integrative medicine, 2009, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Cytarabine; Daunorubicin; Drugs, Chinese Herbal; Etoposide; Female; Humans; Immunophenotyping; Integrative Medicine; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Treatment Outcome; Young Adult	2009
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Combined Modality Therapy; Confidence Intervals; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Probability; Proportional Hazards Models; Radiotherapy, Adjuvant; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome	2010
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma. British journal of haematology, 2008, Volume: 141, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Vincristine	2008
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood, 1995, Oct-15, Volume: 86, Issue:8 Topics: Acute Disease; Adolescent; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Immunophenotyping; Infant; Leukemia, Myeloid; Neoplastic Stem Cells; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Treatment Outcome	1995
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood, 1994, Sep-01, Volume: 84, Issue:5 Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation	1994
Anthracycline drugs and MDR expression in human leukemia. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome	1996
Analysis of human sperm karyotypes in testicular cancer patients before and after chemotherapy. Cytogenetics and cell genetics, 1997, Volume: 78, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Chromosome Aberrations; Cisplatin; Etoposide; Humans; Karyotyping; Male; Sequence Analysis, DNA; Spermatozoa; Testicular Neoplasms	1997
Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS. British journal of haematology, 1998, Volume: 102, Issue:3 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gene Rearrangement; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Recurrence; Survival Analysis; Treatment Outcome	1998
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine	2001
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Medical and pediatric oncology, 2001, Volume: 36, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Diseases; Chemotherapy, Adjuvant; Child; Child, Preschool; Chromosome Aberrations; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Gene Amplification; Genes, myc; Humans; Hypothyroidism; Immunization, Passive; Immunoconjugates; Immunoglobulin G; Iodine Radioisotopes; Neoplasm Proteins; Neoplasm Staging; Neuroblastoma; Radioimmunotherapy; Radiotherapy, Adjuvant; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine	2001
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Interferon-alpha; Karyotyping; Lenograstim; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Predictive Value of Tests; Prednisone; Prognosis; Recombinant Proteins; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome; United Kingdom; Vincristine	2001
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas. Annals of hematology, 2001, Volume: 80 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine	2001
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Apr-15, Volume: 20, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoxantrone; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Survival Analysis; Thiotepa; Vincristine	2002
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood, 1992, Dec-15, Volume: 80, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Analysis; Time Factors	1992

Other Studies

109 other study(ies) available for etoposide and Abnormalities, Autosome

Article	Year
Alternative end-joining originates stable chromosome aberrations induced by etoposide during targeted inhibition of DNA-PKcs in ATM-deficient tumor cells. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, 2022, Volume: 30, Issue:4 Topics: Ataxia Telangiectasia Mutated Proteins; Cell Line; Chromosome Aberrations; DNA; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA Repair; DNA-Activated Protein Kinase; Etoposide; Humans	2022
Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites. Genes, chromosomes & cancer, 2021, Volume: 60, Issue:12 Topics: Binding Sites; CCCTC-Binding Factor; Cell Cycle Proteins; Chondroitin Sulfate Proteoglycans; Chromosomal Proteins, Non-Histone; Chromosome Aberrations; Cohesins; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Gene Rearrangement; Genome, Human; HeLa Cells; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Male; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Poly-ADP-Ribose Binding Proteins	2021
Concentration-response studies of the chromosome-damaging effects of topoisomerase II inhibitors determined in vitro using human TK6 cells. Mutation research. Genetic toxicology and environmental mutagenesis, 2019, Volume: 841 Topics: Cell Line; Chromosome Aberrations; DNA Topoisomerases, Type II; Etoposide; Humans; Kinetochores; Micronucleus Tests; Topoisomerase II Inhibitors	2019
Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology reports, 2013, Volume: 29, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome Aberrations; Core Binding Factors; Cytarabine; Disease-Free Survival; Etoposide; Exons; Female; Humans; Idarubicin; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Prognosis; Proto-Oncogene Proteins c-kit; Retrospective Studies; Stem Cell Transplantation; Young Adult	2013
Induction of centrosome amplification by formaldehyde, but not hydroquinone, in human lymphoblastoid TK6 cells. Environmental and molecular mutagenesis, 2015, Volume: 56, Issue:6 Topics: Aneuploidy; Cell Line; Centrosome; Chromosome Aberrations; Dose-Response Relationship, Drug; Etoposide; Formaldehyde; Humans; Hydroquinones; Lymphocytes; Melphalan	2015
Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, 2015, Volume: 23, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Chromosome Aberrations; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Etoposide; G2 Phase; Gene Rearrangement; HeLa Cells; Histones; Homologous Recombination; Humans; Mitotic Index; MRE11 Homologue Protein; Protein Binding; Rad51 Recombinase; Sister Chromatid Exchange	2015
Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations. Mutation research. Genetic toxicology and environmental mutagenesis, 2015, Volume: 793 Topics: Adult; Chromosome Aberrations; Chromosomes, Human; Cytogenetic Analysis; Dexrazoxane; DNA End-Joining Repair; DNA Topoisomerases, Type II; Etoposide; Humans; Lymphocytes; Male; Resting Phase, Cell Cycle; Topoisomerase II Inhibitors; X-Rays	2015
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Dec-20, Volume: 33, Issue:36 Topics: Adolescent; Anthracyclines; Antineoplastic Agents; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Disease-Free Survival; Etoposide; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Induction Chemotherapy; International Cooperation; Kaplan-Meier Estimate; Karyotype; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Mutation; Predictive Value of Tests; Proto-Oncogene Proteins c-kit; ras Proteins; Retrospective Studies; Translocation, Genetic; Transplantation, Homologous; Treatment Outcome	2015
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma, 2016, Volume: 57, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chromosome Aberrations; Cytarabine; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Retreatment; Staurosporine; Treatment Outcome; Young Adult	2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-10, Volume: 34, Issue:23 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bleomycin; Chemoradiotherapy; Chromosome Aberrations; Chromosomes, Human, Pair 9; Disease-Free Survival; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Gene Amplification; Hodgkin Disease; Humans; In Situ Hybridization, Fluorescence; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Programmed Cell Death 1 Ligand 2 Protein; Risk Factors; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2016
[Influence of Acetylcysteine on Cytogenetic Effects of Etoposide in Mouse Oocytes]. Genetika, 2016, Volume: 52, Issue:2 Topics: Acetylcysteine; Animals; Chromosome Aberrations; Etoposide; Female; Mice; Mutagenesis; Mutagens; Oocytes	2016
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 2017, Volume: 102, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53	2017
Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. European journal of haematology, 2008, Volume: 81, Issue:3 Topics: Animals; Antigens, CD34; Antineoplastic Agents; Base Sequence; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromosome Aberrations; Etoposide; Gene Expression Profiling; Hematopoietic Stem Cells; Humans; Lipids; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction	2008
Etoposide-treatment and MLL rearrangements. European journal of haematology, 2008, Volume: 81, Issue:6 Topics: Animals; Antigens, CD34; Antineoplastic Agents; Base Sequence; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromosome Aberrations; Etoposide; Gene Expression Profiling; Hematopoietic Stem Cells; Humans; Lipids; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction	2008
Etoposide-initiated MLL rearrangements: the pitfalls of inverse PCR. European journal of haematology, 2008, Volume: 81, Issue:6 Topics: Animals; Antigens, CD34; Antineoplastic Agents; Base Sequence; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromosome Aberrations; Etoposide; Gene Expression Profiling; Hematopoietic Stem Cells; Humans; Lipids; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction	2008
Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:4 Topics: Animals; Antineoplastic Agents; Bone Marrow; Chromosome Aberrations; Etoposide; Glutathione; Lipid Peroxidation; Male; Mice; Micronucleus Tests; Oxidative Stress; Razoxane	2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Annals of hematology, 2009, Volume: 88, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult	2009
Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms. Toxicological sciences : an official journal of the Society of Toxicology, 2009, Volume: 110, Issue:2 Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosome Aberrations; Cisplatin; Cluster Analysis; DNA Adducts; DNA Breaks, Double-Stranded; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Profiling; Gene Expression Regulation; Humans; Laboratories; Mutagenicity Tests; Mutagens; Observer Variation; Paclitaxel; Polymerase Chain Reaction; Reproducibility of Results; Risk Assessment; Sodium Chloride; Spindle Apparatus; Time Factors	2009
Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis, 2009, Volume: 30, Issue:9 Topics: Antigens, CD34; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromosome Aberrations; Embryonic Stem Cells; Etoposide; Gene Rearrangement; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Myeloid-Lymphoid Leukemia Protein	2009
The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2. PloS one, 2009, Sep-07, Volume: 4, Issue:9 Topics: Acetyltransferases; Camptothecin; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Chromosome Aberrations; Chromosome Segregation; Cohesins; Congenital Abnormalities; DNA Damage; Etoposide; Fibroblasts; Growth Disorders; Humans; Infant; Male; Mitomycin; Nucleic Acid Synthesis Inhibitors; Sister Chromatid Exchange; Syndrome	2009
Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutation research, 2010, Jan-05, Volume: 683, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Blotting, Southern; Chromosome Aberrations; Chromosome Painting; Cinnamates; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Female; Ganciclovir; Humans; Hygromycin B; In Situ Hybridization, Fluorescence; Ovarian Neoplasms; Peptide Elongation Factor 1; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Promoter Regions, Genetic; Thymidine Kinase; Tumor Cells, Cultured	2010
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results. American journal of hematology, 2010, Volume: 85, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Chromosome Aberrations; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous; Vidarabine; Young Adult	2010
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion. Neuro-oncology, 2011, Volume: 13, Issue:1 Topics: Adolescent; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Child; Child, Preschool; Chromosome Aberrations; Comet Assay; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Polymorphism, Single Nucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2011
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia. Leukemia, 2011, Volume: 25, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Chromosome Aberrations; Disease Progression; DNA Methylation; Etoposide; Female; Humans; Interferon Regulatory Factors; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Proteins; Promoter Regions, Genetic	2011
Chromatin mobility is increased at sites of DNA double-strand breaks. Journal of cell science, 2012, May-01, Volume: 125, Issue:Pt 9 Topics: Cell Line, Tumor; Cell Nucleus; Chromatin; Chromosome Aberrations; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Etoposide; Fluorescence; Gamma Rays; Humans; Intracellular Signaling Peptides and Proteins; Models, Molecular; Motion; Plasmids; Staining and Labeling; Time-Lapse Imaging; Transfection; Tumor Suppressor p53-Binding Protein 1	2012
Interlaboratory assessment of mitotic index by flow cytometry confirms superior reproducibility relative to microscopic scoring. Environmental and molecular mutagenesis, 2012, Volume: 53, Issue:4 Topics: Adult; Benzo(a)pyrene; Chromosome Aberrations; Cyclophosphamide; Etoposide; Flow Cytometry; Humans; Lymphocytes; Mitomycin; Mitotic Index; Regression Analysis	2012
Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells. Molecular carcinogenesis, 2013, Volume: 52, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Proliferation; Chromosome Aberrations; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Gene Expression Regulation; Gene Knockdown Techniques; Genomic Instability; HEK293 Cells; Histones; Humans; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rad51 Recombinase	2013
Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients. Annals of hematology, 2012, Volume: 91, Issue:9 Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chromosome Aberrations; Cohort Studies; Comorbidity; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Immunophenotyping; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid; Male; Palliative Care; Remission Induction; Retrospective Studies; Serbia; Treatment Outcome	2012
[Genetic prognostic factors in childhood acute myeloid leukemia]. Klinische Padiatrie, 2012, Volume: 224, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cytarabine; DNA Mutational Analysis; Etoposide; Female; fms-Like Tyrosine Kinase 3; Genes, Wilms Tumor; Genetic Markers; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Nuclear Proteins; Nucleophosmin; Prognosis; Survival Rate; Translocation, Genetic	2012
DNA-PKcs-dependent NHEJ pathway supports the progression of topoisomerase II poison-induced chromosome aberrant cells. Environmental and molecular mutagenesis, 2012, Volume: 53, Issue:8 Topics: Animals; Cell Cycle; Cell Line; CHO Cells; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; Etoposide; G1 Phase; G2 Phase; Idarubicin; Micronuclei, Chromosome-Defective	2012
A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma. Journal of Korean medical science, 2002, Volume: 17, Issue:4 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Cells; Carmustine; Chromosome Aberrations; Chromosomes, Human, Pair 11; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pelvis; Pregnancy; Pregnancy Complications, Neoplastic; Transplantation, Autologous	2002
Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines. Leukemia, 2002, Volume: 16, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Division; Chromosome Aberrations; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Flow Cytometry; Humans; Karyotyping; Leukemia; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2002
Chromosomal instability in B-lymphoblasotoid cell lines from Werner and Bloom syndrome patients. Mutation research, 2002, Sep-26, Volume: 520, Issue:1-2 Topics: 4-Nitroquinoline-1-oxide; B-Lymphocytes; Bloom Syndrome; Camptothecin; Carcinogens; Case-Control Studies; Cell Division; Cell Line; Chromosome Aberrations; Etoposide; Herpesvirus 4, Human; Humans; Karyotyping; Metaphase; Micronuclei, Chromosome-Defective; Mitomycin; Sister Chromatid Exchange; Werner Syndrome	2002
Molecular cytogenetic analysis in mouse sperm of chemically induced aneuploidy: studies with topoisomerase II inhibitors. Mutation research, 2002, Sep-26, Volume: 520, Issue:1-2 Topics: Aneuploidy; Animals; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Chromosome Aberrations; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epididymis; Etoposide; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Male; Meiosis; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Spermatocytes; Thiobarbiturates; Topoisomerase II Inhibitors	2002
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Acute Disease; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Inversion; Chromosomes, Human; Cladribine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplastic Stem Cells; Recurrence; Remission Induction; Tetrazolium Salts; Thiazoles; Translocation, Genetic; Trisomy	2002
Chromosomal aberrations induced by 5-azacytidine combined with VP-16 (etoposide) in CHO-K1 and XRS-5 cell lines. Teratogenesis, carcinogenesis, and mutagenesis, 2003, Volume: Suppl 1 Topics: Animals; Azacitidine; Cell Cycle; Cell Line; CHO Cells; Chromosome Aberrations; Cricetinae; Cytogenetic Analysis; Drug Combinations; Drug Interactions; Etoposide; Kinetics; Mutagens; Radiation Tolerance	2003
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine	2003
PAINT/DAPI analysis of mouse zygotes to detect paternally transmitted chromosomal aberrations. Advances in experimental medicine and biology, 2003, Volume: 518 Topics: Abnormalities, Drug-Induced; Acrylamide; Animals; Chromosome Aberrations; Etoposide; Female; Fluorescent Dyes; Genetic Techniques; In Situ Hybridization, Fluorescence; Indoles; Male; Mice; Paternal Exposure; Spermatocytes; Spermatozoa; Time Factors; Zygote	2003
Destructive effect of DNA topoisomerase II inhibitor vepesid on mouse spermatogenesis. Bulletin of experimental biology and medicine, 2003, Volume: 135, Issue:5 Topics: Animals; Cell Differentiation; Cell Division; Chromosome Aberrations; DNA Topoisomerases, Type II; Etoposide; Male; Mice; Mice, Inbred CBA; Nucleic Acid Synthesis Inhibitors; Spermatocytes; Spermatogenesis; Testis; Topoisomerase II Inhibitors	2003
Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells. Bulletin of experimental biology and medicine, 2003, Volume: 136, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chromatids; Chromosome Aberrations; Chromosomes; Culture Media; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Humans; Karyotyping; Lymphoma; Mutagens; Vidarabine	2003
Distribution of breakpoints induced by etoposide and X-rays along the CHO X chromosome. Cytogenetic and genome research, 2004, Volume: 104, Issue:1-4 Topics: Animals; CHO Cells; Chromatids; Chromosome Aberrations; Chromosome Breakage; Chromosome Mapping; Cricetinae; Cricetulus; DNA; DNA Damage; Enzyme Inhibitors; Etoposide; Female; S Phase; Topoisomerase II Inhibitors; X Chromosome	2004
Investigations into the biological relevance of in vitro clastogenic and aneugenic activity. Cytogenetic and genome research, 2004, Volume: 104, Issue:1-4 Topics: Alkylating Agents; Amsacrine; Aneuploidy; Cells, Cultured; Chromosome Aberrations; Chromosomes, Human; Cytochalasin B; DNA Damage; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Gene Expression Profiling; Guanine; Humans; Lymphocytes; Methyl Methanesulfonate; Micronucleus Tests; Mutagens; Oxyquinoline; Risk; Topoisomerase II Inhibitors	2004
Etoposide exposure during male mouse pachytene has complex effects on crossing-over and causes nondisjunction. Mutation research, 2004, Dec-31, Volume: 565, Issue:1 Topics: Animals; Chromosome Aberrations; Chromosomes; Crossing Over, Genetic; Etoposide; In Situ Hybridization, Fluorescence; Male; Mice; Microsatellite Repeats; Nondisjunction, Genetic; Nucleic Acid Synthesis Inhibitors; Pachytene Stage; Spermatozoa	2004
Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour? British journal of neurosurgery, 2004, Volume: 18, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Cisplatin; Craniopharyngioma; Etoposide; Fatal Outcome; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms	2004
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutation research, 2005, Jun-06, Volume: 583, Issue:2 Topics: Animals; Area Under Curve; Azure Stains; Bone Marrow Cells; Chromosome Aberrations; Chromosome Painting; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Infusions, Intravenous; Macaca mulatta; Neutropenia; Paclitaxel; Thiotepa	2005
Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents. Mutation research, 2005, Aug-01, Volume: 585, Issue:1-2 Topics: Adult; Aneugens; Cells, Cultured; Chromosome Aberrations; Etoposide; Female; Flow Cytometry; Griseofulvin; Humans; Lymphocytes; Male; Mitomycin; Mitosis; Mutagenicity Tests; Paclitaxel; Polyploidy	2005
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Statistics, Nonparametric; Survival Analysis	2005
Etoposide induces chromosomal abnormalities in mouse spermatocytes and stem cell spermatogonia. Human reproduction (Oxford, England), 2006, Volume: 21, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; Chromosome Aberrations; Etoposide; In Situ Hybridization, Fluorescence; Male; Meiosis; Mice; Spermatocytes; Spermatogonia; Stem Cells	2006
Decatenation checkpoint deficiency in stem and progenitor cells. Cancer cell, 2005, Volume: 8, Issue:6 Topics: Animals; Cell Differentiation; Cell Division; Cell Line; Chromosome Aberrations; Diketopiperazines; Etoposide; Genes, cdc; Hematopoietic Stem Cells; Humans; Mice; Neurons; Piperazines; Stem Cells; Time Factors	2005
Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. The Journal of clinical investigation, 2006, Volume: 116, Issue:1 Topics: Bone Neoplasms; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Chromosome Aberrations; Chromosome Banding; Chromosomes, Human, Pair 11; Cloning, Molecular; Etoposide; G2 Phase; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Myeloid-Lymphoid Leukemia Protein; Osteosarcoma; Translocation, Genetic	2006
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemo International journal of oncology, 2006, Volume: 28, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Cell Line, Tumor; Chromosome Aberrations; Chromosome Banding; Chromosome Breakage; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Female; Genome, Human; Humans; Male; Nucleic Acid Hybridization; Polymerase Chain Reaction; Spectral Karyotyping; Translocation, Genetic	2006
Dangerous entanglements. Trends in molecular medicine, 2006, Volume: 12, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Transformation, Neoplastic; Chromosome Aberrations; Diketopiperazines; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; G2 Phase; Genomic Instability; Humans; Piperazines; Regenerative Medicine; Stem Cell Transplantation; Stem Cells; Topoisomerase II Inhibitors	2006
Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Mutation research, 2007, Mar-01, Volume: 616, Issue:1-2 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; Enzyme Inhibitors; Etoposide; Micronuclei, Chromosome-Defective; Micronucleus Tests; Thiobarbiturates; Time Factors; Topoisomerase II Inhibitors	2007
Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements. Gene, 2007, Apr-15, Volume: 391, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Chromatin Immunoprecipitation; Chromosome Aberrations; Chromosome Breakage; Core Binding Factor Alpha 2 Subunit; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Jurkat Cells; Leukemia; Neoplasms; Protein Binding; Rad52 DNA Repair and Recombination Protein; Recombination, Genetic; Topoisomerase II Inhibitors	2007
Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks. Mutation research, 1994, Nov-01, Volume: 311, Issue:1 Topics: Antineoplastic Agents; Cell Survival; Chromosome Aberrations; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Sister Chromatid Exchange; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1994
Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo. Mutation research, 1993, Volume: 301, Issue:2 Topics: Analysis of Variance; Animals; Bone Marrow Cells; Chromosome Aberrations; Ciprofloxacin; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Male; Mice; Mutagenicity Tests; Mutagens; Sister Chromatid Exchange	1993
DNA topoisomerase II inhibition and gene amplification in V79/B7 cells. Mutation research, 1993, Volume: 301, Issue:3 Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Benzamides; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Dihydroorotase; DNA Damage; DNA Repair; Drug Resistance; Etoposide; Gene Amplification; Multienzyme Complexes; Phosphonoacetic Acid; Topoisomerase II Inhibitors	1993
Hypersensitivity of lymphoblastoid lines derived from ataxia telangiectasia patients to the induction of chromosomal aberrations by etoposide (VP-16). Mutation research, 1993, Volume: 290, Issue:2 Topics: Ataxia Telangiectasia; Cell Cycle; Cell Line; Chromosome Aberrations; DNA Damage; DNA Replication; Dose-Response Relationship, Drug; Etoposide; Female; G2 Phase; Humans; Lymphocytes; Male; Mitotic Index; Mutagens; S Phase	1993
Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells. Mutation research, 1995, Volume: 328, Issue:2 Topics: 2,4-Dinitrophenol; Aclarubicin; Adenosine Triphosphate; Animals; Camptothecin; Cells, Cultured; Chromosome Aberrations; Cricetinae; Dinitrophenols; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Fibroblasts; Topoisomerase II Inhibitors	1995
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation	1995
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome	1995
Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis. Cancer, 1994, Sep-01, Volume: 74, Issue:5 Topics: Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic	1994
Etoposide (VP-16): cytogenetic studies in mice. Environmental and molecular mutagenesis, 1994, Volume: 23, Issue:3 Topics: Analysis of Variance; Animals; Cell Cycle; Chromosome Aberrations; Dose-Response Relationship, Drug; Etoposide; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Mutagenicity Tests; Mutagens; S Phase; Sister Chromatid Exchange	1994
Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells. Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:2 Topics: Aclarubicin; Animals; Camptothecin; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Doxorubicin; Etoposide; Fibroblasts; Lung; Mitoxantrone; Sister Chromatid Exchange; Topoisomerase I Inhibitors	1994
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia, 1993, Volume: 7, Issue:12 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Cisplatin; Cohort Studies; Denmark; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Female; Germinoma; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Regression Analysis; Risk	1993
Etoposide and secondary haematological malignancies: coincidence or causality? Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Chromosome Aberrations; Chromosome Disorders; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Karyotyping; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary	1993
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma. The American journal of pediatric hematology/oncology, 1993, Volume: 15, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 11; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Risk; Vincristine	1993
Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells. Mutation research, 1996, Feb-15, Volume: 362, Issue:2 Topics: Adenine Phosphoribosyltransferase; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; CHO Cells; Chromosome Aberrations; Cricetinae; Diketopiperazines; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Mutagenesis; Mutagenicity Tests; Nucleic Acid Heteroduplexes; Piperazines; Recombination, Genetic; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transfection	1996
Numerical and structural chromosome aberrations induced by etoposide (VP16) during oocyte maturation of mice: transmission to one-cell zygotes and damage to dictyate oocytes. Mutagenesis, 1996, Volume: 11, Issue:4 Topics: Aneuploidy; Animals; Antineoplastic Agents, Phytogenic; Chromosome Aberrations; Etoposide; Female; Humans; Male; Mice; Mice, Inbred ICR; Mutagens; Oocytes; Zygote	1996
[CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8 Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, CD7; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Etoposide; Gene Rearrangement; HLA-DR Antigens; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Leukemia; Membrane Glycoproteins; Mitoxantrone; N-Glycosyl Hydrolases; Prednisolone; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Skin Neoplasms; Thymoma; Thymus Neoplasms	1996
Differentiation induction therapy with all-trans retinoic acid (ATRA) in a patient with secondary 11q23 leukemia. Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 11; Cytarabine; Drug Resistance, Multiple; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Translocation, Genetic; Tretinoin	1996
Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy. Environmental and molecular mutagenesis, 1997, Volume: 29, Issue:1 Topics: Aneuploidy; Animals; Antineoplastic Agents; Cell Cycle; Chromosome Aberrations; Chromosome Banding; CREST Syndrome; Enzyme Inhibitors; Etoposide; Immunohistochemistry; Kinetochores; Male; Meiosis; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mitosis; Seminiferous Tubules; Spermatids; Spermatozoa; Staining and Labeling; Thiobarbiturates; Topoisomerase II Inhibitors	1997
Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations. Mutagenesis, 1997, Volume: 12, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Chromosome Aberrations; DNA; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; KB Cells; Topoisomerase II Inhibitors; Tritium	1997
Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Human genetics, 1997, Volume: 99, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Chromosome Aberrations; Cisplatin; Etoposide; Humans; In Situ Hybridization, Fluorescence; Male; Spermatozoa; Testicular Neoplasms	1997
Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts. Cytogenetics and cell genetics, 1997, Volume: 76, Issue:1-2 Topics: Cell Line; Chromosome Aberrations; Chromosomes; DNA Probes; Enzyme Inhibitors; Etoposide; Fibroblasts; Humans; In Situ Hybridization, Fluorescence; Mitosis; Topoisomerase II Inhibitors	1997
Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques. Mutagenesis, 1998, Volume: 13, Issue:1 Topics: Amsacrine; Azure Stains; Chromosome Aberrations; Chromosome Banding; Etoposide; Humans; Male; Staining and Labeling; Topoisomerase II Inhibitors; Translocation, Genetic	1998
New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis. Bone marrow transplantation, 1998, Volume: 21, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Retrospective Studies; Transplantation, Autologous; Whole-Body Irradiation	1998
Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Mutation research, 1998, Jun-05, Volume: 401, Issue:1-2 Topics: Alkylating Agents; Antineoplastic Agents; Aphidicolin; Apoptosis; B-Lymphocytes; Cell Division; Cell Line; Chromosome Aberrations; Cytarabine; DNA Replication; Etoposide; Humans; Hydroxyurea; Methotrexate; Mutagenesis; Nucleic Acid Synthesis Inhibitors; Radiation, Ionizing; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53	1998
DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutation research, 1998, May-25, Volume: 400, Issue:1-2 Topics: Animals; Aphidicolin; Bromodeoxyuridine; Cell Count; Cell Cycle; CHO Cells; Chromosome Aberrations; Cricetinae; DNA; Etoposide; Flow Cytometry; Mutagenicity Tests; Mutagens; Nucleic Acid Synthesis Inhibitors; Topoisomerase I Inhibitors	1998
Effects of poly(ADP-ribose) polymerase inhibition on cell death and chromosome damage induced by VP16 and bleomycin. Environmental and molecular mutagenesis, 1998, Volume: 32, Issue:1 Topics: Apoptosis; Bleomycin; Cell Cycle; Cells, Cultured; Chromosome Aberrations; Etoposide; Flow Cytometry; Humans; Mutagens; Poly(ADP-ribose) Polymerase Inhibitors	1998
The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutation research, 1998, Nov-09, Volume: 419, Issue:1-3 Topics: Base Sequence; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; DNA Nucleotidyltransferases; Etoposide; Humans; Lymphocytes; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; VDJ Recombinases	1998
Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II. Chromosoma, 1998, Volume: 107, Issue:6-7 Topics: Amsacrine; Animals; CHO Cells; Chromatids; Chromosome Aberrations; Chromosome Segregation; Cricetinae; Demecolcine; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Interphase; Metaphase; Mitoxantrone; Nucleic Acid Synthesis Inhibitors; Topoisomerase II Inhibitors	1998
Human sperm chromosome complements in chemotherapy patients and infertile men. Chromosoma, 1998, Volume: 107, Issue:6-7 Topics: Adult; Antineoplastic Agents; Bleomycin; Chromosome Aberrations; Cisplatin; Etoposide; Humans; In Situ Hybridization, Fluorescence; Infertility, Male; Male; Meiosis; Middle Aged; Spermatozoa	1998
Analysis of sperm chromosome complements before, during, and after chemotherapy. Cancer genetics and cytogenetics, 1999, Jan-15, Volume: 108, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosomes, Human; Cisplatin; Etoposide; Humans; Male; Spermatozoa; Testicular Neoplasms	1999
[Pleiotropic changes in karyotype structure of Chinese hamster fibroblast cell lint CHL V-79 RJK in relation to their acquisition of resistance to etoposide, an inducer of apoptosis]. Tsitologiia, 1999, Volume: 41, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Damage; Drug Resistance; Enzyme Inhibitors; Etoposide; Fibroblasts; Karyotyping; Phenotype; Topoisomerase I Inhibitors	1999
Quantitative measurement of mammalian chromosome mitotic loss rates using the green fluorescent protein. Journal of cell science, 1999, Volume: 112 ( Pt 16) Topics: Aneuploidy; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Buffers; Caffeine; Cell Fusion; Chromosome Aberrations; Chromosomes, Artificial, Yeast; Demecolcine; Etoposide; Flow Cytometry; Glucose; Green Fluorescent Proteins; HeLa Cells; Humans; In Situ Hybridization, Fluorescence; Indicators and Reagents; Luminescent Proteins; Mammals; Mice; Mitosis; Nocodazole; Phosphodiesterase Inhibitors; Plasmids; Yeasts	1999
Possible association of BLM in decreasing DNA double strand breaks during DNA replication. The EMBO journal, 2000, Jul-03, Volume: 19, Issue:13 Topics: Adenosine Triphosphatases; Amino Acid Sequence; Animals; Base Sequence; Bloom Syndrome; Camptothecin; Cell Cycle; Cells, Cultured; Chickens; Chromosome Aberrations; DNA Damage; DNA Helicases; DNA Primers; DNA Repair Enzymes; DNA Replication; Etoposide; Fungal Proteins; Methyl Methanesulfonate; Molecular Sequence Data; RecQ Helicases; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid	2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study Leukemia, 2000, Volume: 14, Issue:7 Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Child; Chromosome Aberrations; Chromosome Inversion; Chromosomes, Human; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Life Tables; Male; Multicenter Studies as Topic; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Remission Induction; Risk Assessment; Risk Factors; Survival Analysis; Thioguanine; Translocation, Genetic; Treatment Failure; Treatment Outcome; United States	2000
Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Middle Aged	2000
Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. Proceedings of the National Academy of Sciences of the United States of America, 2001, Mar-27, Volume: 98, Issue:7 Topics: Aneuploidy; Animals; Antineoplastic Agents, Phytogenic; Chromosome Aberrations; Chromosomes; Etoposide; Karyotyping; Male; Meiosis; Metaphase; Mice; Spermatocytes; Translocation, Genetic	2001
Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide. Mutation research, 2001, May-09, Volume: 476, Issue:1-2 Topics: Aneuploidy; Animals; Chromosome Aberrations; Cricetinae; Cricetulus; Enzyme Inhibitors; Etoposide; Female; Meiosis; Metaphase; Oocytes; Topoisomerase II Inhibitors	2001
Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. Journal of cell science, 2002, Jan-01, Volume: 115, Issue:Pt 1 Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Transformed; Cell Nucleus; Chromosome Aberrations; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA Repair; DNA-Binding Proteins; Etoposide; Fibroblasts; Gene Expression; Humans; Immunohistochemistry; Microscopy, Fluorescence; Microscopy, Immunoelectron; Nucleic Acid Synthesis Inhibitors; Rad51 Recombinase; Radiation, Ionizing; Rats; Transfection; Ultraviolet Rays	2002
Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro. Mutation research, 2002, Feb-20, Volume: 499, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Benzothiazoles; Cell Cycle; Cell Survival; Chromosome Aberrations; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Humans; In Vitro Techniques; Karyotyping; Lymphocytes; Thiazoles; Time Factors; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2002
Werner and Bloom helicases are involved in DNA repair in a complementary fashion. Oncogene, 2002, Jan-31, Volume: 21, Issue:6 Topics: 4-Nitroquinoline-1-oxide; Adenosine Triphosphatases; Amino Acid Sequence; Animals; B-Lymphocytes; Bloom Syndrome; Camptothecin; Cell Cycle; Cell Line; Chickens; Chromosome Aberrations; Clone Cells; Coculture Techniques; DNA; DNA Damage; DNA Helicases; DNA Repair; Drug Resistance; Etoposide; Gene Targeting; Humans; Methyl Methanesulfonate; Molecular Sequence Data; Mutagenicity Tests; Radiation Tolerance; RecQ Helicases; Sequence Alignment; Sequence Homology, Amino Acid; Sister Chromatid Exchange; Species Specificity; Ultraviolet Rays; Werner Syndrome	2002
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia. European journal of haematology, 2001, Volume: 67, Issue:4 Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cohort Studies; Cytarabine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Lipopolysaccharide Receptors; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplastic Stem Cells; Thioguanine; Treatment Outcome	2001
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chromosome Aberrations; Chromosomes, Human, Pair 12; Diagnosis, Differential; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Paclitaxel; Pelvic Neoplasms; Seminoma	2001
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. Teratology, 1978, Volume: 18, Issue:1 Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Chromosomes; Colchicine; Etoposide; Female; Gestational Age; Maytansine; Mice; Pregnancy; Teniposide; Teratogens; Vincristine	1978
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis. Journal of cell science, 1992, Volume: 103 ( Pt 1) Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	1992
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood, 1992, Nov-01, Volume: 80, Issue:9 Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine	1992
Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood, 1992, Apr-15, Volume: 79, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Cytarabine; Daunorubicin; DNA, Neoplasm; Etoposide; Female; Genetic Linkage; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic; Tretinoin; X Chromosome	1992
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome. Clinical genetics, 1992, Volume: 41, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction	1992
Sperm chromosome studies in individuals treated for testicular cancer. Human reproduction (Oxford, England), 1990, Volume: 5, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cisplatin; Etoposide; Female; Genetic Testing; Humans; Male; Sperm-Ovum Interactions; Spermatozoa; Testicular Neoplasms; Vinblastine	1990
Human cells (normal and ataxia telangiectasia) transfected with pR plasmid are hypersensitive to DNA strand-breaking agents. Mutation research, 1991, Volume: 255, Issue:1 Topics: Ataxia Telangiectasia; Bleomycin; Cell Line, Transformed; Cell Survival; Chromosome Aberrations; DNA Damage; DNA Repair; Etoposide; Fibroblasts; Herpesvirus 4, Human; Humans; Lymphocytes; Plasmids; SOS Response, Genetics; Transfection	1991
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet (London, England), 1991, Aug-10, Volume: 338, Issue:8763 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cisplatin; Cohort Studies; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Risk Factors	1991
Chromosome aberrations induced by etoposide (VP-16) are not random. International journal of cancer, 1990, Nov-15, Volume: 46, Issue:5 Topics: Adult; Chromosome Aberrations; Chromosomes; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 4; Chromosomes, Human, Pair 5; Etoposide; Female; Genetic Variation; Humans; Male; X Chromosome	1990
Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells. Cancer research, 1988, Feb-01, Volume: 48, Issue:3 Topics: Amsacrine; Animals; Camptothecin; Cell Line; Cell Survival; Chromosome Aberrations; Cricetinae; Drug Resistance; Ellipticines; Etoposide; Mitomycin; Mitomycins; Sister Chromatid Exchange; Topoisomerase II Inhibitors	1988
Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung. Blood, 1985, Volume: 66, Issue:6 Topics: Acute Disease; Carcinoma, Small Cell; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Lomustine; Lung Neoplasms; Male; Methotrexate; Preleukemia; Risk; Vincristine	1985
Cytogenetic effects of multiagent chemotherapy on the peripheral lymphocytes of patients with small cell lung cancer. Japanese journal of cancer research : Gann, 1986, Volume: 77, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromosome Aberrations; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Sister Chromatid Exchange; Vincristine	1986
Cytogenetic effects of etoposide (VP-16) on human lymphocytes; with special reference to the relation between sister chromatid exchange and chromatid breakage. Japanese journal of cancer research : Gann, 1986, Volume: 77, Issue:4 Topics: Cells, Cultured; Chromosome Aberrations; Etoposide; Humans; Karyotyping; Lymphocytes; Podophyllotoxin; Sister Chromatid Exchange	1986